Amandeep (Aman) S. Sidhu is a partner in the Litigation practice group with substantial experience representing companies in high stakes disputes, including clients across the health care, life science and pharmaceutical industries. Aman’s commitment to client service and delivering results is reflected in his recent recognition as a “40 Under 40” by the Washington Business Journal, “DC Rising Star” by The National Law Journal, “Rising Star” by the Minority Corporate Counsel Association, and “Best Under 40” by the National Asian Pacific American Bar Association.
Aman focuses his practice on compliance counseling, state and federal government investigations, and complex civil litigation and disputes involving regulated industries. He regularly represents hospitals and health care companies in defense of qui tam whistleblower litigation involving the False Claims Act (FCA), Stark Law and Anti-Kickback Statute in federal district courts throughout the United States. Aman also advises clients on risk management issues arising in the US and internationally, including compliance with the Foreign Corrupt Practice Act (FCPA).
Aman serves on the Firm’s Diversity/Inclusion Committee and Pro Bono and Community Service Committee.
Previously, Aman was a judicial clerk for the Chief Judge Walter S. Felton, Jr., of the Court of Appeals of Virginia. While clerking, he was a member of the National Association of Appellate Court Attorneys and was appointed by Supreme Court of Virginia Chief Justice Leroy R. Hassell, Sr., to serve as a task force member of the Commission on Virginia Courts in the 21st Century: To Benefit All, To Exclude None. Prior to law school, he was a business analyst for the Federal Defense Group of American Management Systems, Inc. While in law school, Aman was an associate editor of the Richmond Journal of Law and the Public Interest, vice president of the Moot Court Board and president of the Student Bar Association.
Aman is also a co-founder of the Sikh Coalition, a civil/human rights nonprofit organization and, in that capacity, has led lobbying efforts in US Congress regarding hate crimes, profiling and workplace and public accommodation discrimination and serves as lead counsel in a multi-year effort to end the US military’s presumptive ban on the service of observant Sikhs and other religious minorities.
Represents several national health care providers in internal and government investigations, compliance and regulatory counseling matters, and active state and federal litigation; current active clients include hospitals, health systems, health plans, medical practice groups, and companies focused on life sciences, telemedicine and pharmaceutical development
Defended a regional health system in non-intervened FCA qui tamlitigation that resulted in settlement that fully resolved all claims in United States ex rel. Markley v. Spartanburg Regional Health Services District, Inc. (D.S.C. 2017)
Represents the largest shipbuilding company in the United States in various regulatory matters, including FCPA compliance
Led cross-office and inter-departmental team representing leading life science company in multi-pronged investigation arising from the company’s production of cells used in medical research; investigations spanned several Senate and House committee investigations—including a House Select Panel investigation—as well as two state investigations; representation also included health regulatory guidance and coordination of parallel civil litigation
Defended a regional health system in an intervened qui tam matter that resulted in negotiating the settlement of FCA allegations constituting more than $1 billion in alleged damages in United States ex rel. Kunz v. Halifax Health, et al. (M.D. Florida 2014); also obtained summary judgment for Halifax Health for non-intervened FCA allegations representing more than $450 million in alleged damages for Anti-Kickback Statute, Stark Law and Medicare lack of medical necessity violation
Represented five hospitals and health systems around the United States responding to FCA allegations related to kyphoplasty (an orthopedic procedure) stemming from a sealed qui tam complaint filed in the Western District of New York
Actively represents several major regional hospital systems in Certificate of Need (CON) and other state regulatory matters in Virginia, Maryland and Washington, DC, including associated litigation
Won the unprecedented reversal of a CON denial for The George Washington University Hospital in Washington, DC, to establish a kidney and pancreas transplant program
Obtained CON and other regulatory approvals for American Hospice, the nation’s first hospice management company in the District of Columbia
Gained regulatory approval for a record $1 billion renovation and expansion of Inova Fairfax Hospital, the largest hospital in Northern Virginia
Achieved landmark CON exemption for Breast Care for Washington that allowed the organization to launch mammography services in Washington DC’s Ward 8, providing access to critical services for the District’s underserved population
Represented multiple health care management organizations in response to congressional inquiries that preceded the passage of the Patient Protection and Affordable Care Act in 2010
Achieved a settlement for a large agricultural cooperative in response to alleged violations of the Commodity Exchange Act in Anderson, et al. v. Dairy Farmers of America, Inc. (D. Minn.)
Serves as lead pro bono counsel for a campaign to ensure that observant Sikhs may freely serve in the US military, resulting in over 20 clients being granted landmark religious accommodations allowing them to serve in the US Army with distinction while maintaining their religious articles of faith; efforts in this eight-year campaign resulted in the US Army’s adoption of an historic new policy in January 2017 that substantially lifts the obstacles to Sikhs and other religious minorities seeking religious accommodations
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.